Factories on Autopilot, Brain Implants at Scale, and a $2.1B Insurance AI Bet
About this episode
Lumaril raises $66M Series A to deploy AI above factory control systems, NeuroXess closes $105M Series B to run clinical trials and mass manufacturing simultaneously, Guidewire acquires hyperexponential for up to $2.1B in agentic underwriting push
Chapters
Sources & Citations
Lumaril raises $66M Series A to run factories on autopilot | Dealroom
dealroom.co
Lumaril raises $66 million at a $400 million valuation for AI that sits on top of factory control systems | Complete AI Training
completeaitraining.com
Lumaril Raises $66 Million Series A at $400 Million Valuation to Expand Industrial AI Platform | Pulse 2.0
pulse2.com
Palantir Foundry Creators' Lumaril Raises $66M at $400M | FourWeekMBA
fourweekmba.com
Brain-computer interface startup NeuroXess raises RMB 700 million in Series B funding | TechNode
technode.com
China's NeuroXess raises $105M Series B as brain implant enters clinical trial | Dealroom
dealroom.co
NeuroXess Raises RMB 700 Million to Advance Implantable BCI Trials and Manufacturing | The World of Implantable Devices
www.implantable-device.com
China Applies its Industrial Playbook to Brain Chips | The Wire China
www.thewirechina.com
Guidewire Signs Definitive Agreement to Acquire hyperexponential (Official Press Release)
www.guidewire.com
Guidewire buys Hyperexponential for $1.7B in cash | TechCrunch
techcrunch.com
Guidewire agrees $1.7bn deal for AI underwriting and pricing software firm hyperexponential | Reinsurance News
www.reinsurancene.ws
Guidewire Software Bets $2.1B on Hyperexponential to Lead AI Underwriting | Yahoo Finance
finance.yahoo.com